Cover Image

Angioimmunoblastic T-cell lymphoma unmasked by treatment with dupilumab

Saved in:

Bibliographic Details
Main Authors:	Zi-Yi Choo, BS (Author), Adesola A. Akinyemi, MD, MPH (Author), Thomas Cibull, MD (Author), Stephanie Mehlis, MD (Author), Jason B. Waldinger, MD (Author)
Format:	Book
Published:	Elsevier, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relapsed angioimmunoblastic T-cell lymphoma presenting as psoriasiform dermatitis
by: Spencer McClure, MD, et al.
Published: (2023)

Angioimmunoblastic T-cell lymphoma associated with immune checkpoint inhibitor treatment
by: Taylor C. Duke, MD, et al.
Published: (2020)

Did dupilumab unmask smoldering mycosis fungoides?
by: Michelle Toker, BS, et al.
Published: (2023)

CUTANEOUS MANIFESTATIONS OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA
by: N. G. Chernova, et al.
Published: (2018)

Epstein-Barr virus-positive, CD30-positive, diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma
by: Marc Grossman, MD, et al.
Published: (2022)

Cutaneous involvement in angioimmunoblastic T-cell lymphoma
by: Papadavid Evangelia, et al.
Published: (2010)

Erythema Multiforme Major in Angioimmunoblastic T-cell Lymphoma
by: Shoko Hattori, et al.
Published: (2021)

Angioimmunoblastic T-Cell Lymphoma: A Diagnostic Challenge
by: Jorge Ocampo-Garza, et al.
Published: (2014)

Angioimmunoblastic T-cell Lymphoma: A Case Report
by: Sundus Nasim, et al.
Published: (2024)

Acceleration of cutaneous T-cell lymphoma following dupilumab administration
by: Kristen Russomanno, MD, et al.
Published: (2021)

Diagnosis of Angioimmunoblastic T Cell Lymphoma After Receiving First Dose of Pfizer/BioNTech (BNT162b2) Vaccine: A Case Report
by: Jai Kumar Khatri MD, et al.
Published: (2024)

Unmasking a T cell lymphoma: Folliculotropic mycosis fungoides with a gamma-delta phenotype
by: Jessica Tran, BBA, et al.
Published: (2020)

A rare case of aggressive cytotoxic T-cell lymphoma in a patient on dupilumab
by: Renat Ahatov, BSA, et al.
Published: (2022)

Lethal anaplastic large-cell lymphoma occurring in a patient treated with dupilumab
by: Aurélie Du-Thanh, MD, PhD, et al.
Published: (2021)

Rapidly progressing necrotic hand ulcer in a patient with angioimmunoblastic T‐cell lymphoma
by: Hua Xian Elizabeth Wang, et al.
Published: (2023)

Angioimmunoblastic T-Cell lymphoma: A critical analysis of clinical, morphologic and immunophenotypic features
by: Bal Munita, et al.
Published: (2010)

Angioimmunoblastic Lymphadenopathy
by: Nandakishore B, et al.
Published: (2002)

Angioimmunoblastic T-Cell Lymphoma Mimicking Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS Syndrome)
by: Joanna Mangana, et al.
Published: (2017)

Predicting the efficiency of chidamide in patients with angioimmunoblastic T-cell lymphoma using machine learning algorithm
by: Chunlan Zhang, et al.
Published: (2024)

Refractory facial cutaneous B-cell pseudolymphoma successfully treated with dupilumab
by: Kalisa Lum, BS, et al.
Published: (2024)

Comment on "Multibacillary leprosy unmasked by COVID-19 vaccination"
by: Vinod Hanumanthu, MD, et al.
Published: (2022)

Dupilumab-induced pityriasis rosea
by: Morgan Zabel, BS, et al.
Published: (2023)

Bilateral axillary pigmented lesions in a melanoma patient
by: Shannon Gurley, BS, et al.
Published: (2023)

Secondary Cutaneous Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma with Hodgkin/Reed-Sternberg-like Cells in a Patient with Angioimmunoblastic T-cell Lymphoma
by: Hao Chen, et al.
Published: (2018)

Multibacillary leprosy unmasked by COVID-19 vaccination
by: Shashendra Aponso, MD, MRCP, et al.
Published: (2022)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021)

Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature
by: Yang Qing-Xu, et al.
Published: (2012)

An unusual case of calciphylaxis in a psoriatic patient without kidney disease
by: Maria Mihailescu, BS, et al.
Published: (2021)

Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
by: Joshua D. Bloomstein, BS, et al.
Published: (2021)

Porphyria cutanea tarda unmasked by supratherapeutic estrogen during gender-affirming hormone therapy
by: Stephanie R. Jackson Cullison, MD, PhD, et al.
Published: (2020)

Dupilumab-induced erythema nodosum
by: Danielle E. Mustin, MEng, et al.
Published: (2022)

Oral diffuse large B-cell lymphoma presenting as a bland nodule
by: Guilherme Kuceki, BS, et al.
Published: (2023)

Lichen planus pemphigoides successfully treated with dupilumab
by: Peter Yi Ch'en, BS, et al.
Published: (2023)

Epidermolysis bullosa pruriginosa responding to dupilumab
by: Rebecca C. Clawson, BS, et al.
Published: (2021)

Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas
by: Ingrid Lazaridou, et al.
Published: (2020)

Resolution of dupilumab-associated alopecia areata with dosage modification
by: Maansi Kulkarni, BS, et al.
Published: (2022)

Peristomal irritant contact dermatitis treated with dupilumab
by: Emma Villamaria, BSA, et al.
Published: (2023)

Ulcerative injection-site reaction associated with dupilumab therapy
by: Michael Phan, BS, et al.
Published: (2020)

Infectious pseudochromhidrosis in the setting of dupilumab use
by: Molly E. Kuo, BS, et al.
Published: (2022)

Renal infarction due to polyarteritis nodosa in a patient with angioimmunoblastic T-cell lymphoma: a case report and a brief review of the literature
by: Ambrosio Maria, et al.
Published: (2012)